Find-Health-Articles.com - making medical research available to everyone
Research article summary (published 30 Aug 2008):

Individualized continuation electroconvulsive therapy and medication as a bridge to relapse prevention after an index course of electroconvulsive therapy in severe mood disorders: a naturalistic 3-year cohort study.

Full Abstract

Electroconvulsive therapy (ECT) is recognized as an effective acute treatment for mood disorders but is associated with high risk of relapse. To minimize this risk, we introduced as a routine individually tapered continuation ECT with concomitant medication (C-ECT + Med) after an index series in January 2000. In August 2002, a chart review of all patients (n = 41) who had received C-ECT + Med for more than 4 months was carried out. Sixteen patients also participated in an extensive interview. Mean duration of administered C-ECT at follow-up was 1 year, but for most patients (63%), C-ECT had been terminated. For 49% of patients, adjustments between ECT sessions had been made due to early signs of relapse. Two weeks was the most common interval between sessions for patients with ongoing C-ECT. The frequency of lithium-treated patients had increased from 12% before index to 41% during C-ECT. However, the rated response to the drug varied. Need for hospital care 3 years before and after the initiation of C-ECT + Med was compared in a second evaluation of the cohort. The number of patients hospitalized, number of admissions, and total days in hospital were all significantly reduced. Hospital days were reduced by 76% (P < 0.001). Three patients with previously cumulative years in hospital are described as case vignettes after 6 years with no or minimal need for further hospitalization. This study supports previous findings that individually tapered C-ECT + Med can maintain initial response to ECT and serve as a bridge to long-term relapse prevention.

 

Author information

Author/s: Odeberg, Håkan (H); Rodriguez-Silva, Bruce (B); Salander, Pirjo (P); Mårtensson, Björn (B);

Affiliation: Department of Psychiatry, Karolinska University Hospital, Huddinge, Stockholm, Sweden. hodeberg(-atsign-)gmail.com

Journal and publication information

Publication Type: Case Reports; Journal Article

Journal: The journal of ECT (J ECT), published in United States. (Language: eng)

Reference: 2008-Sep; vol 24 (issue 3) : pp 183-90

Dates: Created 2008/09/08; Completed 2009/01/22;

PMID: 18695624, status: MEDLINE (last retrieval date: 2/18/2009, IMS Date: )

Sourced from the National Library of Medicine. Abstract text and other information may be subject to copyright.

Comments and Corrections

CommentIn: J ECT. 2008 Sep;24(3):177-8. (PMID: 18772701)

External Links for this article
(including full text providers, if available):

Click Electronic Full-text Provider Links to see options for finding the electronic full text links to this article. Note there may be a subscription or fee required for access to the full text. See our FAQ for information on finding FREE full text articles.

This article may also be located in paper journal collections available in many libraries. Use the Journal and Publication Information above to find the full article.

MeSH headings (categories)

This article was linked to the MESH Headings shown below.

Associated Chemicals: Psychotropic Drugs (0)

Related articles

These are the highest related articles currently in the database:

See 100+ related articles.

Related Article Map

12/30/1986
8/30/2008
Higher Relevance Score (29)
Lower Relevance Score (22)

Legend: - FREE Full text Article. - Abstract only. - Title only. More help.

See a large map of 100+ related articles.

© Advanogy LLC 2003-2009 - All rights reserved. Terms of Use | Contact Us | Index